Cardiol Therapeutics Inc. Class A (CRDL)
NASDAQ: CRDLHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
CRDL stock chart
Technical analysisKey statistics
All statistics- Market cap
- $160.40M
- EPS (TTM)
- -$0.25
- Dividend yield
- None
- 52-week range
- 0.88 – 2.34
- Day range
- 1.29 – 1.38
- Volume / Avg
- 3.73M / 1.39M
- Beta
- —
- Shares outstanding
- 121.51M
- Next earnings
- Nov 12, 2026
52-week range
CRDL stock today
Cardiol Therapeutics (CRDL) closed at $1.32 on Oct 7, up 0.76% (+$0.01), versus the S&P 500's 0.22% decline. Volume was 2.7x the average at 3.73M shares, a sign of unusually heavy trading. Shares are 43.6% below their 52-week high of $2.34, set on Sep 9, 2026 and 50.0% above the 52-week low of $0.88, in the middle of the past year's range.
CRDL is up 38.4% year to date, outperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has gained 24.5%. Cardiol Therapeutics has posted a net loss over the last twelve months (EPS of -$0.25), so its P/E ratio is not meaningful. Cardiol Therapeutics's next earnings report is expected on Nov 12, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Cardiol Therapeutics
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Headquarters
- Oakville
Earnings
Earnings history- Next report
- Nov 12, 2026
Cardiol Therapeutics peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| CHRSCoherus Oncology Inc. | 1.01 | -1.94% | $156.05M | vs CRDL |
| TARAProtara Therapeutics Inc. | 2.59 | +1.37% | $153.06M | vs CRDL |
| VYGRVoyager Therapeutics Inc. | 2.47 | +0.41% | $152.20M | vs CRDL |
| ABOSAcumen Pharmaceuticals Inc. | 2.10 | +3.45% | $151.87M | vs CRDL |
| IPHAInnate Pharma S.A. ADS | 1.52 | -4.40% | $169.78M | vs CRDL |
| MOLNMolecular Partners AG ADR | 3.81 | +0.79% | $145.94M | vs CRDL |
| OTLKOutlook Therapeutics Inc. | 0.59 | +3.15% | $143.63M | vs CRDL |
| DTILPrecision BioSciences Inc. | 6.25 | +0.81% | $172.51M | vs CRDL |
Indexes, lists and sector
Cardiol Therapeutics stock FAQ
What is Cardiol Therapeutics's stock price today?
CRDL last traded at $1.32 as of Oct 7, 4:00 PM EDT, up 0.76% on the day. Prices are delayed at least 15 minutes.
When is Cardiol Therapeutics's next earnings date?
Cardiol Therapeutics is expected to report earnings on Thursday, November 12, 2026.
What is the CRDL 52-week high?
The 52-week high for CRDL is $2.34 and the 52-week low is $0.88. The stock is currently 43.6% below its high.